IBDEI0G2 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16088,1,2,0)
 ;;=2^99214
 ;;^UTILITY(U,$J,358.3,16089,0)
 ;;=99215^^63^771^5
 ;;^UTILITY(U,$J,358.3,16089,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16089,1,1,0)
 ;;=1^Comprehensive
 ;;^UTILITY(U,$J,358.3,16089,1,2,0)
 ;;=2^99215
 ;;^UTILITY(U,$J,358.3,16090,0)
 ;;=99241^^63^772^1
 ;;^UTILITY(U,$J,358.3,16090,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16090,1,1,0)
 ;;=1^Problem Focused
 ;;^UTILITY(U,$J,358.3,16090,1,2,0)
 ;;=2^99241
 ;;^UTILITY(U,$J,358.3,16091,0)
 ;;=99242^^63^772^2
 ;;^UTILITY(U,$J,358.3,16091,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16091,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,16091,1,2,0)
 ;;=2^99242
 ;;^UTILITY(U,$J,358.3,16092,0)
 ;;=99243^^63^772^3
 ;;^UTILITY(U,$J,358.3,16092,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16092,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,16092,1,2,0)
 ;;=2^99243
 ;;^UTILITY(U,$J,358.3,16093,0)
 ;;=99244^^63^772^4
 ;;^UTILITY(U,$J,358.3,16093,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16093,1,1,0)
 ;;=1^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,16093,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,16094,0)
 ;;=99245^^63^772^5
 ;;^UTILITY(U,$J,358.3,16094,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16094,1,1,0)
 ;;=1^Comprehensive, High
 ;;^UTILITY(U,$J,358.3,16094,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,16095,0)
 ;;=99024^^63^773^1
 ;;^UTILITY(U,$J,358.3,16095,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16095,1,1,0)
 ;;=1^Post-Op Follow-up Visit
 ;;^UTILITY(U,$J,358.3,16095,1,2,0)
 ;;=2^99024
 ;;^UTILITY(U,$J,358.3,16096,0)
 ;;=D61.1^^64^774^7
 ;;^UTILITY(U,$J,358.3,16096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16096,1,3,0)
 ;;=3^Anemia,Aplastic,Drug-Induced
 ;;^UTILITY(U,$J,358.3,16096,1,4,0)
 ;;=4^D61.1
 ;;^UTILITY(U,$J,358.3,16096,2)
 ;;=^5002336
 ;;^UTILITY(U,$J,358.3,16097,0)
 ;;=D61.2^^64^774^6
 ;;^UTILITY(U,$J,358.3,16097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16097,1,3,0)
 ;;=3^Anemia,Aplastic d/t External Agents
 ;;^UTILITY(U,$J,358.3,16097,1,4,0)
 ;;=4^D61.2
 ;;^UTILITY(U,$J,358.3,16097,2)
 ;;=^5002337
 ;;^UTILITY(U,$J,358.3,16098,0)
 ;;=D61.89^^64^774^9
 ;;^UTILITY(U,$J,358.3,16098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16098,1,3,0)
 ;;=3^Anemia,Aplastic/Bone Marrow Failure Syndromes
 ;;^UTILITY(U,$J,358.3,16098,1,4,0)
 ;;=4^D61.89
 ;;^UTILITY(U,$J,358.3,16098,2)
 ;;=^5002341
 ;;^UTILITY(U,$J,358.3,16099,0)
 ;;=D61.9^^64^774^8
 ;;^UTILITY(U,$J,358.3,16099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16099,1,3,0)
 ;;=3^Anemia,Aplastic,Unspec
 ;;^UTILITY(U,$J,358.3,16099,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,16099,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,16100,0)
 ;;=D59.0^^64^774^10
 ;;^UTILITY(U,$J,358.3,16100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16100,1,3,0)
 ;;=3^Anemia,Drug-Induced Autoimmune Hemolytic
 ;;^UTILITY(U,$J,358.3,16100,1,4,0)
 ;;=4^D59.0
 ;;^UTILITY(U,$J,358.3,16100,2)
 ;;=^5002323
 ;;^UTILITY(U,$J,358.3,16101,0)
 ;;=D62.^^64^774^20
 ;;^UTILITY(U,$J,358.3,16101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16101,1,3,0)
 ;;=3^Anemia,Posthemorrhagic,Acute
 ;;^UTILITY(U,$J,358.3,16101,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,16101,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,16102,0)
 ;;=D64.81^^64^774^1
 ;;^UTILITY(U,$J,358.3,16102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16102,1,3,0)
 ;;=3^Anemia d/t Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,16102,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,16102,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,16103,0)
 ;;=D63.1^^64^774^4
 ;;^UTILITY(U,$J,358.3,16103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16103,1,3,0)
 ;;=3^Anemia in Chr Kidney Disease
 ;;^UTILITY(U,$J,358.3,16103,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,16103,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,16104,0)
 ;;=D63.0^^64^774^5
 ;;^UTILITY(U,$J,358.3,16104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16104,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,16104,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,16104,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,16105,0)
 ;;=D63.8^^64^774^3
 ;;^UTILITY(U,$J,358.3,16105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16105,1,3,0)
 ;;=3^Anemia in Chr Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,16105,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,16105,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,16106,0)
 ;;=D51.8^^64^774^27
 ;;^UTILITY(U,$J,358.3,16106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16106,1,3,0)
 ;;=3^Anemia,Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,16106,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,16106,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,16107,0)
 ;;=D51.1^^64^774^2
 ;;^UTILITY(U,$J,358.3,16107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16107,1,3,0)
 ;;=3^Anemia d/t Selective Vit B12 Malabsorption w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,16107,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,16107,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,16108,0)
 ;;=D53.9^^64^774^19
 ;;^UTILITY(U,$J,358.3,16108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16108,1,3,0)
 ;;=3^Anemia,Nutritional,Unspec
 ;;^UTILITY(U,$J,358.3,16108,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,16108,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,16109,0)
 ;;=D52.9^^64^774^13
 ;;^UTILITY(U,$J,358.3,16109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16109,1,3,0)
 ;;=3^Anemia,Folate Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,16109,1,4,0)
 ;;=4^D52.9
 ;;^UTILITY(U,$J,358.3,16109,2)
 ;;=^5002293
 ;;^UTILITY(U,$J,358.3,16110,0)
 ;;=D52.0^^64^774^11
 ;;^UTILITY(U,$J,358.3,16110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16110,1,3,0)
 ;;=3^Anemia,Folate Deficiency,Dietary
 ;;^UTILITY(U,$J,358.3,16110,1,4,0)
 ;;=4^D52.0
 ;;^UTILITY(U,$J,358.3,16110,2)
 ;;=^5002290
 ;;^UTILITY(U,$J,358.3,16111,0)
 ;;=D52.1^^64^774^12
 ;;^UTILITY(U,$J,358.3,16111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16111,1,3,0)
 ;;=3^Anemia,Folate Deficiency,Drug-Induced
 ;;^UTILITY(U,$J,358.3,16111,1,4,0)
 ;;=4^D52.1
 ;;^UTILITY(U,$J,358.3,16111,2)
 ;;=^5002291
 ;;^UTILITY(U,$J,358.3,16112,0)
 ;;=D59.9^^64^774^14
 ;;^UTILITY(U,$J,358.3,16112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16112,1,3,0)
 ;;=3^Anemia,Hemolytic,Acquired
 ;;^UTILITY(U,$J,358.3,16112,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,16112,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,16113,0)
 ;;=D59.1^^64^774^15
 ;;^UTILITY(U,$J,358.3,16113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16113,1,3,0)
 ;;=3^Anemia,Hemolytic,Autoimmune
 ;;^UTILITY(U,$J,358.3,16113,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,16113,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,16114,0)
 ;;=D58.9^^64^774^16
 ;;^UTILITY(U,$J,358.3,16114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16114,1,3,0)
 ;;=3^Anemia,Hemolytic,Hereditary,Unspec
 ;;^UTILITY(U,$J,358.3,16114,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,16114,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,16115,0)
 ;;=D59.4^^64^774^17
 ;;^UTILITY(U,$J,358.3,16115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16115,1,3,0)
 ;;=3^Anemia,Hemolytic,Nonautoimmune
 ;;^UTILITY(U,$J,358.3,16115,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,16115,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,16116,0)
 ;;=D58.0^^64^774^30
 ;;^UTILITY(U,$J,358.3,16116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16116,1,3,0)
 ;;=3^Spherocytosis,Hereditary
 ;;^UTILITY(U,$J,358.3,16116,1,4,0)
 ;;=4^D58.0
 ;;^UTILITY(U,$J,358.3,16116,2)
 ;;=^5002321
 ;;^UTILITY(U,$J,358.3,16117,0)
 ;;=D50.9^^64^774^18
 ;;^UTILITY(U,$J,358.3,16117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16117,1,3,0)
 ;;=3^Anemia,Iron Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,16117,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,16117,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,16118,0)
 ;;=D61.82^^64^774^28
 ;;^UTILITY(U,$J,358.3,16118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16118,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,16118,1,4,0)
 ;;=4^D61.82
